AAD 2026Abstract 73392Clinical trial
Bimekizumab time to clinical response and achievement of clinically meaningful improvement thresholds in Chinese patients with psoriasis from the BE SHINING phase 3 trial
Cai L, Man XY, Wang J, Wei A, Chen Y, Gao J, Hoepken B, Sun W, Lei T, Zhang J
AAD Annual Meeting 2026Denver, 27–31 Mar 2026 · published in JAAD 6 Jul 2026
Topics: Psoriasis
Abstract
The abstract’s text is on the JAAD website.
DOI 10.1016/j.jaad.2026.04.341 · Not in PubMed: details from Crossref